StartUp Health Insights: Pear Suite Closes Seed Round | Week of May 16, 2023
The seed funding expands the StartUp Health portfolio company’s care navigation software and partnerships with a focus on addressing social determinants of health with cultural competency.
Investors, learn how you can back Health Transformers like Colby Takeda of Pear Suite.
Pear Suite, a StartUp Health portfolio company working to empower community health workers and better address the social determinants of health (SDOH), announced the closing of $2.5M in seed funding. The funding will enable the Honolulu, HI-based company to support community health workers to better act on SDOH data as well as expand the company’s efforts within the Asian American and Pacific Islander community. The investment round was led by Mucker Capital, Impact Engine, American Heart Association, Sweater Ventures, and Atento Capital, with support from Techstars, Open Venture Capital, Incisive Ventures, Lair East Labs, StartUp Health, and Third Act Ventures. <source>
Other health innovation funding reported this week included:
Amino Health, a San Francisco, CA-based digital healthcare guidance company, raised $80M led by Transformation Capital and Oxford Finance. <source>
Hippocratic AI, a Palo Alto, CA-based startup building artificial intelligence models for the healthcare industry, raised $50M co-led by General Catalyst and Andreessen Horowitz (A16z). <source>
Embr Labs, a Boston, MA-based maker of a wearable to treat the symptoms of menopause, raised $35M led by GT Investment Partners in collaboration with Aon plc. <source>
Wellthy, a New York, NY-based provider of a care concierge platform, raised $25.5M from Citi Impact Fund, Cercano Management, and Stardust Equity. <source>
Prognos Health, a New York, NY-based real-world integrated data marketplace, raised $23M co-led by Marshall Wace and Safeguard Scientifics, with participation from Cigna Ventures, Hikma Ventures, Hunt Holdings, Labcorp, Maywic, Merck Global Health Innovation Fund, and Red and Blue Ventures. <source>
Diligent Pharma, a Princeton, NJ-based vendor qualification and risk management platform for clinical trials, raised $8.27M led by FCA Venture Partners, with participation from PJC, and GenHenn Capital. <source>
Lavita AI, a San Francisco, CA-based provider of an AI+Web3 healthcare platform, raised $5M led by Camford Capital and angel investors. <source>
FemTherapeutics, a Montreal, QC, Canada-based medtech startup that designs personalized gynecological prosthetics for women suffering from pelvic floor disorders, raised $1.85M led by 2048 Ventures, with participation from Investissement Quebec, The51 Ventures, Sheboot, and angel investors. <source>
Cascade Health, a Seattle, WA-based provider of a healthcare transparency platform, raised $1.7M led by AlleyCorp, with participation from angel investors. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for T1D Innovation
Are you a scientist or innovator focused on T1D innovation who would benefit from education about how to navigate and build a company that will be successful in attracting mission-aligned capital, customers, and collaborators to pursue scientific discoveries in the field of Type 1 diabetes? Learn more and apply for one of the first 25 T1D Fellowships.
Become a Health Moonshot Champion
Health moonshots are fueled by passionate families, foundations, and industry organizations committed to achieving health moonshots. Learn how you can join other champions of the T1D Moonshot or one of our other global health moonshots.
Investors: Learn how you can become a Health Moonshot Champion and invest in Health Transformers.
Digital health entrepreneur? Don’t make the journey alone. Learn how Health Transformer University fuels your health moonshot.
Follow us on social media for daily updates on Health Transformers: Twitter, LinkedIn, Facebook, and Instagram.